Literature DB >> 2694089

The barrier function of the skin in relation to percutaneous absorption of drugs.

J W Wiechers1.   

Abstract

There is currently a high level of interest in using the skin as a route for delivering drugs. The skin, however, provides an efficient barrier against percutaneous absorption of drugs. This barrier function can be ascribed to the macroscopical structure of the stratum corneum, which consists of alternating lipoidal and hydrophylic regions. For this reason, physico-chemical characteristics of the drug, such as partition coefficient and molecular weight, play an important role in determining the facility of percutaneous absorption. Another factor to consider in transdermal drug delivery, is the vehicle in which the drug is formulated as it acts on the release of drug from the formulation. Moreover, vehicles may also interact with human stratum corneum, thereby affecting its barrier function. Surfactants and penetration enhancers are well-known examples of the latter. Subsequently, dosing conditions, such as humidity, temperature and occlusion, also have their impact on the actual input (rate) of drug through human skin. Finally, all bits of information are combined to form a reasonably faithful picture of percutaneous absorption.

Entities:  

Mesh:

Year:  1989        PMID: 2694089     DOI: 10.1007/BF01959410

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  41 in total

1.  EXISTENCE OF RESERVOIR IN THE STRATUM CORNEUM. EXPERIMENTAL PROOF.

Authors:  C F VICKERS
Journal:  Arch Dermatol       Date:  1963-07

2.  Influence of hydration on epidermal tissue.

Authors:  T S Wiedmann
Journal:  J Pharm Sci       Date:  1988-12       Impact factor: 3.534

3.  Use of solubility parameters of drug and vehicle to predict flux through skin.

Authors:  K B Sloan; S A Koch; K G Siver; F P Flowers
Journal:  J Invest Dermatol       Date:  1986-08       Impact factor: 8.551

4.  Thermal analysis of human stratum corneum.

Authors:  B F Van Duzee
Journal:  J Invest Dermatol       Date:  1975-10       Impact factor: 8.551

5.  Methodology to measure the transient effect of occlusion on skin penetration and stratum corneum hydration in vivo.

Authors:  K S Ryatt; M Mobayen; J M Stevenson; H I Maibach; R H Guy
Journal:  Br J Dermatol       Date:  1988-09       Impact factor: 9.302

6.  Skin lipid content during early fetal development.

Authors:  M L Williams; M Hincenbergs; K A Holbrook
Journal:  J Invest Dermatol       Date:  1988-09       Impact factor: 8.551

7.  Drug permeation through human skin II: Permeability of ionizable compounds.

Authors:  J Swarbrick; G Lee; J Brom; N P Gensmantel
Journal:  J Pharm Sci       Date:  1984-10       Impact factor: 3.534

8.  Hydration and percutaneous absorption: I. Influence of hydration on alkanol permeation through hairless mouse skin.

Authors:  C R Behl; G L Flynn; T Kurihara; N Harper; W Smith; W I Higuchi; N F Ho; C L Pierson
Journal:  J Invest Dermatol       Date:  1980-10       Impact factor: 8.551

9.  A rapid method for measuring drug enrichment in epidermis.

Authors:  M Artuc; C Reinhold; G Stüttgen; J Gazith
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

10.  Effect of lipids on the aggregation and permeability of human stratum corneum.

Authors:  W P Smith; M S Christensen; S Nacht; E H Gans
Journal:  J Invest Dermatol       Date:  1982-01       Impact factor: 8.551

View more
  17 in total

1.  Unusual reduction of the in vitro skin permeation of [3H]dexetimide by atropine.

Authors:  I J Bosman; K Ensing; R A de Zeeuw
Journal:  Pharm Res       Date:  1998-01       Impact factor: 4.200

Review 2.  Microneedle-mediated vaccine delivery: harnessing cutaneous immunobiology to improve efficacy.

Authors:  Sharifa Al-Zahrani; Marija Zaric; Cian McCrudden; Chris Scott; Adrien Kissenpfennig; Ryan F Donnelly
Journal:  Expert Opin Drug Deliv       Date:  2012-04-05       Impact factor: 6.648

Review 3.  [Epidermal barrier disorders in dermatoses].

Authors:  E Proksch; D Dähnhardt; R Fölster-Holst
Journal:  Hautarzt       Date:  2016-11       Impact factor: 0.751

4.  Pharmacokinetics and the Dermal Absorption of Bromochlorophene, a Cosmetic Preservative Ingredient, in Rats.

Authors:  Yong-Jae Lee; Hyang-Yeon Kim; Quynh-Lien Pham; Jung-Dae Lee; Kyu-Bong Kim
Journal:  Toxics       Date:  2022-06-16

5.  Buprederm, a new transdermal delivery system of buprenorphine: pharmacokinetic, efficacy and skin irritancy studies.

Authors:  In Park; Dongwon Kim; Jindeog Song; Chang Hoon In; Seung-Wei Jeong; Sang Hun Lee; Bumchan Min; Dongho Lee; Sun-Ok Kim
Journal:  Pharm Res       Date:  2008-02-01       Impact factor: 4.200

6.  Diclofenac sodium topical solution with dimethyl sulfoxide, a viable alternative to oral nonsteroidal anti-inflammatories in osteoarthritis: review of current evidence.

Authors:  Philip Fuller; Sanford Roth
Journal:  J Multidiscip Healthc       Date:  2011-07-11

7.  Development and validation of an alternative disturbed skin model by mechanical abrasion to study drug penetration.

Authors:  P Schlupp; M Weber; T Schmidts; K Geiger; F Runkel
Journal:  Results Pharma Sci       Date:  2014-09-06

8.  Topical application of ALA and ALA hexyl ester on a subcutaneous murine mammary adenocarcinoma: tissue distribution.

Authors:  C Perotti; A Casas; H Fukuda; P Sacca; A Batlle
Journal:  Br J Cancer       Date:  2003-02-10       Impact factor: 7.640

Review 9.  Microneedles for intradermal and transdermal drug delivery.

Authors:  Tuan-Mazlelaa Tuan-Mahmood; Maelíosa T C McCrudden; Barbara M Torrisi; Emma McAlister; Martin J Garland; Thakur Raghu Raj Singh; Ryan F Donnelly
Journal:  Eur J Pharm Sci       Date:  2013-05-13       Impact factor: 4.384

10.  The bioavailability of red ginseng extract fermented by Phellinus linteus.

Authors:  Jae Sik Ryu; Hyun Jung Lee; Song Hwan Bae; Sun Young Kim; Yooheon Park; Hyung Joo Suh; Yoon Hwa Jeong
Journal:  J Ginseng Res       Date:  2013-03       Impact factor: 6.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.